Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.395
-0.010 (-0.71%)
Dec 4, 2025, 3:42 PM AEST
Imricor Medical Systems Market Cap
Imricor Medical Systems has a market cap or net worth of 450.93 million as of December 3, 2025. Its market cap has increased by 102.31% in one year.
Market Cap
450.93M
Enterprise Value
411.98M
Revenue
1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.40
Market Cap Chart
Since August 30, 2019, Imricor Medical Systems's market cap has increased from 87.01M to 450.93M, an increase of 418.25%. That is a compound annual growth rate of 30.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 450.93M | 22.72% |
| Dec 31, 2024 | 367.44M | 281.62% |
| Dec 29, 2023 | 96.28M | 74.29% |
| Dec 30, 2022 | 55.24M | -61.62% |
| Dec 31, 2021 | 143.95M | -49.27% |
| Dec 31, 2020 | 283.74M | 155.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.68B |
| Pro Medicus | 27.39B |
| Cochlear | 18.00B |
| Sonic Healthcare | 11.53B |
| Ramsay Health Care | 8.57B |
| Ansell | 5.21B |
| Telix Pharmaceuticals | 5.10B |
| Mesoblast | 3.43B |